Epibiotech Co., Ltd. (XKON:446440)
South Korea · Delayed Price · Currency is KRW 14,070
+370 (2.70%)
At close: Jun 18, 2026
Epibiotech Market Cap
Epibiotech has a market cap or net worth of 31.1 billion as of June 18, 2026. Its market cap has increased by 25.51% in one year.
Market Cap
31.10B
Enterprise Value
n/a
Revenue
449.62M
Ranking
n/a
PE Ratio
n/a
Stock Price
14,070.00
Market Cap Chart
Since July 31, 2023, Epibiotech's market cap has decreased from 58.59B to 31.10B, a decrease of -46.92%. That is a compound annual growth rate of -19.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 31.10B | -10.13% |
| Dec 30, 2025 | 34.60B | -2.83% |
| Dec 30, 2024 | 35.61B | 24.00% |
| Dec 28, 2023 | 28.72B | -50.98% |
| Jul 31, 2023 | 58.59B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Parataxis Korea | 44.13B |
| Quratis | 44.12B |
| ADBiotech | 43.69B |
| HLB Pep | 42.80B |
| J2KBIO | 41.58B |
| Kainos Medicine | 35.56B |
| Eutilex.Co.,Ltd | 35.32B |
| MOA Life Plus | 24.88B |